Oral calorie supplements for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Smyth, Rosalind L ^a   Rayner, Oli ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CF Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT CHANGE; CALORIC INTAKE; CHILD GROWTH; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; GASTROINTESTINAL DISEASE; HUMAN; LUNG FUNCTION; NUTRITIONAL PARAMETERS; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; CHILD; CHILD NUTRITION DISORDERS; COMPLICATION; META ANALYSIS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; CHILD; CHILD NUTRITION DISORDERS; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; ENERGY INTAKE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84922255773     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000406.pub4     Document Type: Review

References (46)

1. Hanning RM, Blimkie CJR, Bar-Or O, Lands LC, Moss LA, Wilson WM. Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?. American Journal of Clinical Nutrition 1993;57(4):580-7.
2. Kalnins D, Corey M, Ellis L, Pencharz PB, Tullis E, Durie PR. Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics 2005;147(3):399-401.
3. Kalnins D, Durie PR. Oral supplements vs normal food intake in children and adults [abstract]. Israel Journal of Medical Sciences 1996;32:S120-S121.
4. Kalnins D, Durie PR, Corey M, Ellis L, Pencharz P, Tullis E. Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF? [abstract]. Pediatric Pulmonology 1996;Suppl 11:314-5.
5. Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL. Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis [abstract]. Journal of Cystic Fibrosis 2004;3(Suppl 1):S79.
6. Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL. Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis [abstract]. Journal of Cystic Fibrosis 2004;3(Suppl 1):S76.
7. Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL, on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ 2006;332(7542):632-6.
8. Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RS. The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis [abstract]. Pediatric Pulmonology 2004;38(Suppl 27):333.
9. Abdulhamid I, Beck FW, Millard S, Chen X, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatric Pulmonology 2008;43(3):281-7.
10. Abdulhamid I, Millard S, Beck F, Chen X, van Wagnen C, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis [abstract]. Pediatric Pulmonology 2005;40(Suppl 28):348.
11. Best K, McCoy K, Gemma S, Disilvestro RA. Copper enzyme activities in cystic fibrosis before and after supplementation plus or minus zinc. Metabolism 2004;53(1):37-41.
12. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, et al.Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clinical Nutrition 2007;26(3):322-8.
13. Caramia G, Cocchi M, Gagliardini R, Malavolta M, Mozzon M, Frega NG. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture. Pediatria Medica E Chirurgica 2003;25(1):42-9.
14. Ellis L, Kalnins D, Corey M, Brennan J, Pencharz P, Durie P. Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. Journal of Pediatrics 1998;132:270-6.
15. Grey V, Mohammed SR, Smountas A, Bahlool R, Lands L. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. Journal of Cystic Fibrosis 2003;2(4):195-8.
16. Lands LC, Grey VL. Oral supplementation with a bovine whey protein isolate can increase intracellular and sputum glutathione levels in patients with cystic fibrosis [abstract]. Pediatric Pulmonology 2000;Suppl 20:253.
17. Haworth CS, Jones A, Selby PL, Adams JE, Mawer EB, Webb AK. Randomised, double blind, placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adults with cystic fibrosis [abstract]. Pediatric Pulmonology 2001;32(Suppl 22):330-1.
18. Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. Journal of Cystic Fibrosis 2004;3(4):233-6.
19. Kane RE, Hobbs P. Energy and respiratory metabolism in cystic fibrosis: the influence of carbohydrate content of nutritional supplements. Journal of Pediatric Gastroenterology and Nutrition 1991;12:217-23.
20. Lepage G, Yesair DW, Ronco N, Champagne J, Bureau N, Chemtob S, et al.Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis. Journal of Pediatrics 2002;141(2):178-85.
21. Lloyd-Still J, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, et al.A randomized, controlled study examining the bioavailability and safety of an algal docosahexaenoic acid (DHA) triacylglycerol in cystic fibrosis (CF) patients [abstract]. Pediatric Pulmonology 2004;38(Suppl 27):331.
22. Lloyd-Still JD, Powers CA, Hoffman DR, Arterburn LM, Benisek DC, Lester LA. Bioavailability and safety of an algal docosahexaenoic acid (DHA) triglyceride in cystic fibrosis (CF) [abstract]. Pediatric Research 2001;49(4 Suppl):455a.
23. Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Arterburn LM, Benisek DC, et al.Blood and tissue essential fatty acids after docosahexaenoic acid supplementation in cystic fibrosis [abstract]. Pediatric Pulmonology 2001;Suppl 22:263.
24. Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, et al.Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study. Nutrition 2006;22(1):36-46.
25. Powers CA, Lloyd-Still JD, Hoffman DR, Arterburn LM, Benisek DC, Lester LA. Lipid soluble antioxidant status during supplementation with algal docosahexaenoic acid triglyceride in CF [abstract]. Proceedings of 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria. 2001:P133.
26. McKenna MC, Hubbard VS, Bieri JG. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. Journal of Pediatric Gastroenterology and Nutrition 1985;4(1):45-51.
27. Milla C, Doherty L, Raatz S, Schwarzenberg SJ, Regelmann W, Moran A. Glycemic response to dietary supplements in cystic fibrosis is dependent on the carbohydrate content of the formula. Journal of Parenteral and Enteral Nutrition 1996;20:182-6.
28. Oudshoorn JH, Klijn PH, Hofman Z, Voorbij HA, van der Ent CK, Berger R, et al.Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients. Journal of Cystic Fibrosis 2007;6(1):35-40.
29. Papas K, Kalbfleisch J, Mohon R. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Digestive Diseases and Sciences 2007;52(2):347-52.
30. Barrett J. A study to assess the efficacy of Healthshake in the nutritional management of children and adults with cystic fibrosis. Start date: 1/7/98; End date: 30/6/99. National Research Register (UK) http://www.update-software.com/national/ 2001.
31. Patchell C. Personal Communication March 05 2001.
32. Sondel SA, Parrell SW, Becker D, Mischler EH. Oral nutritional supplementation in cystic fibrosis. Nutritional Support Services 1987;7(4):20-2.
33. Koletzko B, Ruhl-Bagheri I, Thiel I, Steinkamp G. Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients [abstract]. Clinical Nutrition 1992;11(Suppl):39-40.
34. Steinkamp G, Demmelmair H, Ruhl-Bagheri I, von der Hardt H, Koletzko B. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. Journal of Pediatric Gastroenterology and Nutrition 2000;31:418-23.
35. MacDonald A. Evaluation of supplementary feed (Healthshake) in the nutritional management of children with cystic fibrosis. Start date: 1/1/97; End date: 1/1/98. National Research Register (UK) http://www.update-software.com/national/ 2001.
36. MacDonald A. Nutritional management of cystic fibrosis. Archives of Disease in Childhood 1996;74(1):81-7.
37. Marin VB, Velandia S, Hunter B, Gattas V, Fielbaum O, Herrara O, et al.Energy expenditure, nutrition status and body composition in children with cystic fibrosis. Nutrition 2004;20(2):181-6.
38. Murray GD. Statistical aspects of research methodology. British Journal of Surgery 1991;78(7):777-81.
39. Poustie V, Rutherford P. Oral protein calorie supplementation for children with chronic disease. Cochrane Database of Systematic Reviews 1999, Issue 3. [DOI: 10.1002/14651858.CD001914].
40. Royal Liverpool Children's Hospital NHS Trust [Pharmacy]. Personal communication 2006.
41. Shepherd R, Cooksley WGE, Cooke WDD. Improved growth and clinical, nutritional and respiratory changes in response to nutritional therapy in cystic fibrosis. Journal of Pediatrics 1980;97(3):351-7.
42. Shepherd RW, Holt TL, Vasques-Velasquez L, Coward WA, Prentice A, Lucas A. Increased energy expenditure in young children with cystic fibrosis. Lancet 1988;I(8598):1300-3.
43. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG. Nutrition in patients with cystic fibrosis; a European consensus. Journal of Cystic Fibrosis 2002;1(4):51-75.
44. Smyth RL, Walters S. Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD000406].
45. Smyth RL, Walters S. Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD000406.pub2].
46. Smyth RL, Walters S. Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD000406.pub3].